Navigation Links
Tamiflu to be examined on clinical efficacy for WHO

Roche’s flu drug Tamiflu, for bird flu, has to be examined for effectiveness in the fight against bird flu in humans. This has been called on by World Health Organization. //

WHO, in a statement from Geneva, said that no clinical evidence of the anti-viral drug's efficacy against the deadly H5N1 virus is there. Therefore urgent studies need to be undertaken.

Still, WHO also approved that Tamiflu should be used to treat suspected cases and to prevent the disease in healthcare workers or others who may have been exposed to infection.

Roche, issued a public statement that it is boosting output of Tamiflu, whose generic name is oseltamivir, by a third to meet increased demand from governments building stockpiles for a potential pandemic triggered by bird flu.

There is no direct clinical trial evidence that shows that oseltamivir is effective in human H5N1 disease because such studies have not yet been conducted, the WHO said in a statement.

The WHO commented that it was possible that severely ill patients might benefit from longer duration of therapy, for example 7-10 days, or perhaps higher doses (for example 300 mg/day), but prospective studies were required.

The WHO recommendations are based on limited data from human outbreaks, animal models, and extrapolated results of trials in patients with ordinary influenza.

Tamiflu is an antiviral drug. It is currently considered the best defence against a human pandemic that could be started by avian flu. But its efficacy has not been proved clinically.

Therefore, tamiflu would be examined for its effectiveness against bird flu
'"/>




Page: 1

Related medicine news :

1. Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid
2. India To Procure 1 Million Doses Of Tamiflu
3. US Reviews Risks Of Tamiflu After 12 Children Die
4. US Regulator Sees No Link Between Tamiflu And Japan Deaths
5. Roche confirms Tamiflu production talks in US
6. Dosage Of Tamiflu Sought To Be Increased
7. Tamiflu Fails To Save Two Lives
8. Christmas trees to yield key Tamiflu ingredient
9. India to produce Tamiflu generic ‘Oseltamivir
10. A success for the Indian pharmacy: gets licence to manufacture Tamiflu
11. Hyderabad Firm To Manufacture Tamiflu In India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... California (PRWEB) , ... August 16, 2017 , ... An August 3rd article ... was the subject of a report in JAMA (the Journal of the American Medical Association). ... 50 were able to achieve BMIs under 30, when compared to patients with lower BMIs. ...
(Date:8/16/2017)... ... 16, 2017 , ... For the second year, the Brain ... educate the public on the impact of concussions. Brooke Mills, student and founder ... Awareness Day. , Brooke is working diligently is to raise awareness of concussion ...
(Date:8/16/2017)... Island, NY (PRWEB) , ... August 16, 2017 , ... ... with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical ... takes much of the guesswork out of a needle stick and more importantly, helps ...
(Date:8/16/2017)... YORK, NY (PRWEB) , ... August 16, 2017 , ... ... for better treatments and ultimately, a cure. , The grants are awarded through ... comprised of scientists with a wide array of backgrounds and expertise in all areas ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
Breaking Medicine Technology: